Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847-875.
Sharma ST, Nieman LK, Feelders RA. Cushing’s syndrome: epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281-293.
Nieman LK, Biller BMK, Findling JW, et al. Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(8):2807-2831.
Braun LT, Vogel F, Zopp S, et al. Whom should we screen for Cushing syndrome? The Endocrine Society practice guideline recommendations 2008 revisited. J Clin Endocrinol Metab. 2022;107(9):e3723-e3730.
Sharma ST, Nieman LK, Feelders RA. Comorbidities in Cushing’s disease. Pituitary. 2015;18(2):188-194.
Hakami OA, Ahmed S, Karavitaki N. Epidemiology and mortality of Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab. 2021;35(1):101521.
Yorke E, Atiase Y, Akpalu J, et al. Screening for Cushing syndrome at the primary care level: what every general practitioner must know. Int J Endocrinol. 2017;2017:1547358.
Savas M, Mehta S, Agrawal N, et al. Approach to the patient: diagnosis of Cushing syndrome. J Clin Endocrinol Metab. 2022;107(11):3162-3174.
Lacroix A, Feelders RA, Stratakis CA, et al. Cushing’s syndrome. Lancet. 2015;386(9996):913-927.
Reincke M, Fleseriu M. Cushing syndrome: a review. JAMA. 2023;330(2):170-181.
Kirk LF, Hash RB, Katner HP, et al. Cushing’s disease: clinical manifestations and diagnostic evaluation [published correction appears in Am Fam Physician. 2002; 65(3): 386]. Am Fam Physician. 2000;62(5):1119-1127.
Valassi E. Clinical presentation and etiology of Cushing’s syndrome: data from ERCUSYN. J Neuroendocrinol. 2022;34(8):e13114.
Balomenaki M, Margaritopoulos D, Vassiliadi DA, et al. Diagnostic workup of Cushing’s syndrome. J Neuroendocrinol. 2022;34(8):e13111.
Nieman LK. Recent updates on the diagnosis and management of Cushing’s syndrome. Endocrinol Metab (Seoul). 2018;33(2):139-146.
Lila AR, Sarathi V, Jagtap VS, et al. Cushing's syndrome: stepwise approach to diagnosis. Indian J Endocrinol Metab. 2011;15(suppl 4):S317-S321.
Piasecka M, Larsson M, Papakokkinou E, et al. Is ectopic Cushing’s syndrome underdiagnosed in patients with small cell lung cancer?. Front Med (Lausanne). 2022;9:954033.
Wengander S, Trimpou P, Papakokkinou E, et al. The incidence of endogenous Cushing’s syndrome in the modern era. Clin Endocrinol (Oxf). 2019;91(2):263-270.
Concepción-Zavaleta MJ, Armas CD, Quiroz-Aldave JE, et al. Cushing disease in pediatrics: an update. Ann Pediatr Endocrinol Metab. 2023;28(2):87-97.
Ferrigno R, Hasenmajer V, Caiulo S, et al. Paediatric Cushing’s disease: epidemiology, pathogenesis, clinical management and outcome. Rev Endocr Metab Disord. 2021;22(4):817-835.
Lodish MB, Keil MF, Stratakis CA. Cushing’s syndrome in pediatrics: an update. Endocrinol Metab Clin North Am. 2018;47(2):451-462.
Nieman LK. Diagnosis of Cushing’s syndrome in the modern era. Endocrinol Metab Clin North Am. 2018;47(2):259-273.
Nieman LK, Biller BMK, Findling JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540.
Braun LT, Riester A, Oßwald-Kopp A, et al. Toward a diagnostic score in Cushing’s syndrome. Front Endocrinol (Lausanne). 2019;10:766.
Rubinstein G, Osswald A, Hoster E, et al. Time to diagnosis in Cushing’s syndrome: a meta-analysis based on 5367 patients. J Clin Endocrinol Metab. 2020;105(3):e12-e22.
Barbot M, Zilio M, Scaroni C. Cushing’s syndrome: overview of clinical presentation, diagnostic tools and complications. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101380.
Erden F, Borlu M, Simsek Y, et al. Differences in skin lesions of endogenous and exogenous Cushing’s patients. Postepy Dermatol Alergol. 2019;36(3):272-275.
Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93(5):1553-1562.
Galm BP, Qiao N, Klibanski A, et al. Accuracy of laboratory tests for the diagnosis of Cushing syndrome. J Clin Endocrinol Metab. 2020;105(6):dgaa105.
Bashari WA, Gillett D, MacFarlane J, et al. Modern imaging in Cushing’s disease. Pituitary. 2022;25(5):709-712.
Wright K, van Rossum EFC, Zan E, et al. Emerging diagnostic methods and imaging modalities in Cushing’s syndrome. Front Endocrinol (Lausanne). 2023;14:1230447.
Grober Y, Grober H, Wintermark M, et al. Comparison of MRI techniques for detecting microadenomas in Cushing’s disease. J Neurosurg. 2018;128(4):1051-1057.
Hall WA, Luciano MG, Doppman JL, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med. 1994;120(10):817-820.
Yip L, Duh QY, Wachtel H, et al. American Association of Endocrine Surgeons guidelines for adrenalectomy: executive summary. JAMA Surg. 2022;157(10):870-877.
Feelders RA, Newell-Price J, Pivonello R, et al. Advances in the medical treatment of Cushing’s syndrome. Lancet Diabetes Endocrinol. 2019;7(4):300-312.
Pivonello R, Ferrigno R, De Martino MC, et al. Medical treatment of Cushing’s disease: an overview of the current and recent clinical trials. Front Endocrinol (Lausanne). 2020;11:648.
Ferriere A, Tabarin A. Cushing’s syndrome: treatment and new therapeutic approaches. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101381.
Buliman A, Tataranu LG, Paun DL, et al. Cushing’s disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment. J Med Life. 2016;9(1):12-18.
Broersen LHA, Jha M, Biermasz NR, et al. Effectiveness of medical treatment for Cushing’s syndrome: a systematic review and meta-analysis. Pituitary. 2018;21(6):631-641.
Gilis-Januszewska A, Bogusławska A, Rzepka E, et al. Individualized medical treatment options in Cushing disease. Front Endocrinol (Lausanne). 2022;13:1060884.
Santos A, Resmini E, Martínez Momblán MA, et al. Quality of life in patients with Cushing’s disease. Front Endocrinol (Lausanne). 2019;10:862.
Mc Bride M, Crespo I, Webb SM, et al. Quality of life in Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab. 2021;35(1):101505.
Keil MF, Zametkin A, Ryder C, et al. Cases of psychiatric morbidity in pediatric patients after remission of Cushing syndrome. Pediatrics. 2016;137(4):e20152234.
Starkman MN. Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinol Metab Clin North Am. 2013;42(3):477-488.
Clayton RN. Cardiovascular complications of Cushings syndrome: impact on morbidity and mortality. J Neuroendocrinol. 2022;34(8):e13175.